PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
15-Sep-2020 FDA grants Dupixent® (dupilumab) Breakthrough Therapy designation for eosinophilic esophagitis Regeneron
15-Sep-2020 Large Prospective Lung Cancer Study To Be Presented at ESMO Congress Shows Idylla™ Reduces EGFR Mutation Testing Turnaround Time by More than a Week, Allowing Faster Patient Management Decisions Biocartis Group NV
15-Sep-2020 Baricitinib in Combination with Remdesivir Reduces Time to Recovery in Hospitalised Patients with COVID-19 in NIAID-Sponsored ACTT-2 Trial Eli Lilly and Company
14-Sep-2020 New real-world data for ONGENTYS®▼ (opicapone) released at the International Congress of Parkinson's Disease and Movement Disorders (MDS) Bial
10-Sep-2020 ReNeuron Group plc - AGM Trading Update ReNeuron Group plc
10-Sep-2020 Thermo Fisher Scientific Opens New Bioprocessing Collaboration Center in St. Louis Thermo Fisher Scientific
10-Sep-2020 Merck Announces € 59 Million Antibody-Drug Conjugate Manufacturing Expansion Merck
10-Sep-2020 HealthTech Innovation Days Announce Details of Conference Program & Attendees HealthTech
10-Sep-2020 ECCRT and IDDI establish partnership for continuous development of IDDI global team members International Drug Development Institute (IDDI)
10-Sep-2020 Clinical trials company urges public to continue involvement in research despite Oxford COVID-19 trial being halted Innovative Trials
10-Sep-2020 Theragnostics Signs Agreement with Summit Biomedical Imaging Enabling the Development of Novel Fluorescence-Based Cancer Diagnostics Theragnostics
10-Sep-2020 Orgenesis CEO to Participate in Webinar Panel on “New Approaches to COVID-19” on Thursday, September 10th Orgenesis
10-Sep-2020 Kallik joins life sciences organisation Medilink West Midlands as newest patron to help drive growth and collaboration in post-COVID times Kallik
10-Sep-2020 AstraZeneca aims to transform cancer treatment and advance clinical practice with data presented at ESMO 2020 AstraZeneca
10-Sep-2020 Avillion announces positive top-line results of Phase 2 trial of sonelokinab (M1095), an anti-IL-17 A/F Nanobody®, in chronic psoriasis Avillion
08-Sep-2020 HRA PHARMA RARE DISEASES: FIRST PROSPECTIVE STUDY CONFIRMS THAT METYRAPONE EFFECTIVELY LOWERS UFC LEVELS IN PATIENTS WITH ENDOGENOUS CUSHING’S SYNDROME HRA Pharma
07-Sep-2020 Signifier Medical Technologies appoints Philip Hess, former President & CEO of Bose Corporation, as Chief Operating Officer Signifier Medical Technologies
07-Sep-2020 PAGE & PAGE AND PARTNERS ANNOUNCES: NEW PARTNERS, NEW LONDON OFFICE, CLIENTS WINS AND RECRUITMENT DRIVE DURING PANDEMIC Page & Page and Partners
07-Sep-2020 Coulter Partners secures Chief Financial Officer for Saniona Coulter Partners
07-Sep-2020 More engineers needed to deliver high tech healthcare – IMechE report The National Health Service